blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2361617

EP2361617 - Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.04.2015
Database last updated on 15.11.2024
Most recent event   Tooltip01.09.2017Lapse of the patent in a contracting state
New state(s): BG, CY, HU		published on 04.10.2017  [2017/40]
Applicant(s)For all designated states
ALLERGAN, INC.
2525 Dupont Drive
Irvine, CA 92612 / US
[N/P]
Former [2011/35]For all designated states
ALLERGAN, INC.
2525 Dupont Drive
Irvine CA 92612 / US
Inventor(s)01 / Huang, Glenn T.
513 Lower Vintners Circle
Fremont, CA 94539 / US
02 / Nivaggioli, Thierry
99 Lupin Lane
Atherton, CA 94027 / US
 [2011/51]
Former [2011/35]01 / Huang, Glenn T.
513 Lower Vintners Circle
Fremont, CA 94539 / US
02 / Nivaggioli, Thierry
12020 Green Hills Court
Los Altos, CA 94022 / US
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[N/P]
Former [2014/24]HOFFMANN EITLE
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München / DE
Former [2011/35]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastraße 4
81925 München / DE
Application number, filing date11161473.121.04.2005
[2011/35]
Priority number, dateUS2004083688030.04.2004         Original published format: US 836880
[2011/35]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2361617
Date:31.08.2011
Language:EN
[2011/35]
Type: B1 Patent specification 
No.:EP2361617
Date:11.06.2014
Language:EN
[2014/24]
Search report(s)(Supplementary) European search report - dispatched on:EP02.08.2011
ClassificationIPC:A61K9/70
[2011/35]
CPC:
A61K9/0051 (EP,US); A61K31/5377 (US); A61P27/02 (EP);
A61P27/06 (EP); A61P43/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/35]
TitleGerman:Intraokulare Implantate mit verzögerter Freigabe mit einem beta-adregenischen Rezeptorantagonisten und Verfahren zur Behandlung okularer Neuropathien[2011/35]
English:Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies[2011/35]
French:Implants intra-oculaires à libération prolongée comprenant un antagoniste du récepteur bêta-adrénergique et procédés pour le traitement de neuropathies[2011/35]
Examination procedure07.04.2011Examination requested  [2011/35]
27.02.2012Amendment by applicant (claims and/or description)
12.12.2013Communication of intention to grant the patent
10.04.2014Fee for grant paid
10.04.2014Fee for publishing/printing paid
10.04.2014Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP05740148.1  / EP1748766
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050740148) is  07.04.2009
Opposition(s)12.03.2015No opposition filed within time limit [2015/21]
Fees paidRenewal fee
07.04.2011Renewal fee patent year 03
07.04.2011Renewal fee patent year 04
07.04.2011Renewal fee patent year 05
07.04.2011Renewal fee patent year 06
07.04.2011Renewal fee patent year 07
25.04.2012Renewal fee patent year 08
29.04.2013Renewal fee patent year 09
28.04.2014Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.04.2005
AT11.06.2014
BE11.06.2014
BG11.06.2014
CY11.06.2014
CZ11.06.2014
EE11.06.2014
FI11.06.2014
LT11.06.2014
MC11.06.2014
PL11.06.2014
RO11.06.2014
SI11.06.2014
SK11.06.2014
GR12.09.2014
IS11.10.2014
PT13.10.2014
[2017/39]
Former [2016/01]AT11.06.2014
BE11.06.2014
CZ11.06.2014
EE11.06.2014
FI11.06.2014
LT11.06.2014
MC11.06.2014
PL11.06.2014
RO11.06.2014
SI11.06.2014
SK11.06.2014
GR12.09.2014
IS11.10.2014
PT13.10.2014
Former [2015/36]AT11.06.2014
BE11.06.2014
CZ11.06.2014
EE11.06.2014
FI11.06.2014
LT11.06.2014
PL11.06.2014
RO11.06.2014
SI11.06.2014
SK11.06.2014
GR12.09.2014
IS11.10.2014
PT13.10.2014
Former [2015/30]AT11.06.2014
BE11.06.2014
CZ11.06.2014
EE11.06.2014
FI11.06.2014
LT11.06.2014
PL11.06.2014
RO11.06.2014
SK11.06.2014
GR12.09.2014
IS11.10.2014
PT13.10.2014
Former [2015/12]AT11.06.2014
CZ11.06.2014
EE11.06.2014
FI11.06.2014
LT11.06.2014
PL11.06.2014
RO11.06.2014
SK11.06.2014
GR12.09.2014
IS11.10.2014
PT13.10.2014
Former [2015/11]CZ11.06.2014
EE11.06.2014
FI11.06.2014
LT11.06.2014
PL11.06.2014
RO11.06.2014
SK11.06.2014
GR12.09.2014
PT13.10.2014
Former [2015/10]CZ11.06.2014
EE11.06.2014
FI11.06.2014
LT11.06.2014
SK11.06.2014
GR12.09.2014
Former [2014/50]FI11.06.2014
LT11.06.2014
GR12.09.2014
Former [2014/49]FI11.06.2014
LT11.06.2014
Former [2014/48]LT11.06.2014
Documents cited:Search[X]EP0430539  (VISIONEX INC [US]) [X] 1-14 * example -; claim - * * page 4, line 5 - line 6 *;
 [X]US4997652  (WONG VERNON G [US]) [X] 1-14 * column 4, line 42 - line 44 * * column 6, line 45 - line 50 * * example -; claim - *;
 [X]US5869079  (WONG VERNON [US], et al) [X] 1-14 * column 3, line 53 - column 4, line 1 * * example - *;
 [X]US6369116  (WONG VERNON [US], et al) [X] 1-14 * column 7, line 12; example - *;
 [X]US6331313  (WONG VERNON G [US], et al) [X] 1-14 * column 10, line 58 - line 60 *;
 [X]US5443505  (WONG VERNON G [US], et al) [X] 1-14 * column 8, line 58 - line 60 * * column 11, line 43 - line 47 *;
 [X]WO03024420  (NOVARTIS AG [CH], et al) [X] 1-14 * page 3, line 1 - line 23 * * page 5, line 10 - line 12 * * example - *;
 [Y]WO0037056  (OCULEX PHARM INC [US], et al) [Y] 1-14 * example -; claim - *;
 [Y]EP0488401  (SENJU PHARMA CO [JP]) [Y] 1-14 * example -; claim - *;
 [X]  - MERKLI A ET AL, "USE OF INSOLUBLE BIODEGRADABLE POLYMERS IN OPHTHALMIC SYSTEMS FOR THE SUSTAINED RELEASE OF DRUGS", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, (19951001), vol. 41, no. 5, ISSN 0939-6411, pages 271 - 283, XP000535194 [X] 1-14 * the whole document *
 [Y]  - WANG Y ET AL, "Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, (200408), vol. 25, no. 18, ISSN 0142-9612, pages 4279 - 4285, XP004497089 [Y] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.biomaterials.2003.10.075
 [Y]  - STURESSON CECILIA ET AL, "Preparation of biodegradable poly(lactic-co-glycolic) aicd microspheres and their in vitro release of timolol maleate", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (1993), Database accession no. PREV199395112456, XP002339576 [Y] 1-14 * the whole document *
    [ ] - INTERNATIONAL JOURNAL OF PHARMACEUTICS (AMSTERDAM), (1993), vol. 89, no. 3, ISSN 0378-5173, pages 235 - 244
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.